Neoadjuvant chemotherapy versus chemoradiotherapy for resectable pancreatic head adenocarcinoma: a propensity score matched analysis. (April 2017) - Mokdad, A.; Minter, R.; Zhu, H.; Augustine, M.; Porembka, M.; Wang, S.; Yopp, A.; Mansour, J.; Choti, M.; Polanco, P.